In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PEOPLE - Xtent makes appointment:

This article was originally published in Clinica

Executive Summary

Drug-eluting stent developer Xtent (Menlo Park, California) has appointed Michael Eagle to its board of directors. Mr Eagle, who has over 30 years experience in the life-sciences industry, was most recently vice-president of manufacturing at Eli Lilly, a post he held for eight years. He is on the board of several companies, including: Favrille (biopharma, chairman); Radiant Medical (endovascular therapeutic cooling); Siegel-Robert (industrial manufacturing); Somaxon Pharmaceutical; and Micrus Endovascular (cerebrovascular implants and disposables).






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts